Guys the below is from an early days presentation. My feeling is that they will sell one and keep one if they actually receive the FDA approval linked to the vouchers.
As for cash flow , I recall Alan saying that a Diagnostic Phase 3 trial costs ballpark 20 Million.
So in my view they will have enough cash to fund the Phase 3 trial just announced to commercialisation.
Guys the below is from an early days presentation. My feeling is...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.22 |
Change
-0.140(2.61%) |
Mkt cap ! $1.625B | |||
| Open | High | Low | Value | Volume |
| $5.36 | $5.50 | $5.18 | $5.452M | 1.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6927 | $5.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.26 | 4319 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$5.22 |
Change
-0.140 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| $5.34 | $5.49 | $5.19 | 94951 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CU6 (ASX) Chart |